New and Evolving Therapies for Cystic Fibrosis Patients

被引：0
|
作者：
Jabar, Alisha [1 ]
Raissy, Hengameh H. [2 ]
Blake, Kathryn [3 ]
机构：
[1] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Hlth Sci Ctr, Dept Pediat, Sch Med, Albuquerque, NM 87131 USA
[3] Nemours Childrens Clin, Biomed Res Dept Floor 1, Jacksonville, FL USA
来源：
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY | 2014年 / 27卷 / 02期
关键词：
MUTATION; ADHERENCE;
D O I：
10.1089/ped.2014.0364
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Cystic fibrosis (CF) is a common autosomal recessive inherited disorder affecting 1 in 2,500 births and similar to 75,000 people in North America, Europe, and Australia. The purpose of this review is to discuss the most recent advances in therapies for CF patients. The CF drug development pipeline provides information regarding the phase of each new therapy and those that are already in use by patients. The ultimate goal of therapy will be to deliver tailored individualized therapies to those who need it the most. This review will focus on new research on CF transmembrane conductance regulator protein modulator agents and the effort of gene therapy.
引用
收藏
页码：92 / 94
页数：3
相关论文
共 50 条
  • [21] Future therapies for cystic fibrosis
    Lucy Allen
    Lorna Allen
    Siobhan B. Carr
    Gwyneth Davies
    Damian Downey
    Marie Egan
    Julian T. Forton
    Robert Gray
    Charles Haworth
    Alexander Horsley
    Alan R. Smyth
    Kevin W. Southern
    Jane C. Davies
    Nature Communications, 14
  • [22] Genetic therapies in cystic fibrosis
    Taylor-Cousar, Jennifer L.
    Boyd, A. Christopher
    Alton, Eric W. F. W.
    Polineni, Deepika
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (06) : 615 - 620
  • [23] Future therapies for cystic fibrosis
    Wilson, Chloe
    LANCET RESPIRATORY MEDICINE, 2022, 10 (08): : E75 - E76
  • [24] Inhaled therapies in cystic fibrosis
    Dubus, J. -C.
    Ravilly, S.
    REVUE DES MALADIES RESPIRATOIRES, 2008, 25 (08) : 989 - 998
  • [25] Progress in therapies for cystic fibrosis
    De Boeck, Kris
    Amaral, Margarida D.
    LANCET RESPIRATORY MEDICINE, 2016, 4 (08): : 662 - 674
  • [26] Genomically-guided therapies: A new era for cystic fibrosis
    Fajac, I
    Girodon, E.
    ARCHIVES DE PEDIATRIE, 2020, 27 : ES41 - ES44
  • [27] Potential impact on fertility of new systemic therapies for cystic fibrosis
    Jones, Gareth Huw
    Walshaw, Martin John
    PAEDIATRIC RESPIRATORY REVIEWS, 2015, 16 : 25 - 27
  • [28] Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis
    Houwen, Roderick H. J.
    van der Woerd, Wendy L.
    Slae, Mordechai
    Wilschanski, Michael
    CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (06) : 551 - 555
  • [29] Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
    Catherinot, Emilie
    Roux, Anne-Laure
    Vibet, Marie-Anne
    Bellis, Gil
    Lemonnier, Lydie
    Le Roux, Evelyne
    Bernede-Bauduin, Claire
    Le Bourgeois, Muriel
    Herrmann, Jean-Louis
    Guillemot, Didier
    Gaillard, Jean-Louis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1101 - 1106
  • [30] Drug Utilization Patterns for Routine Therapies in Patients with Cystic Fibrosis
    Eworuke, Efe
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 474 - 474
12345